Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Peter Bonutti

Orthopaedic Surgery Effingham, IL Medical Doctor

NPI 1629021571 CMS profile 72707

1303 W Evergreen Ave Ste 200, Effingham, IL 62401

Open in the dashboard

General payments

$24,294,201

253 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$574,795

4 holdings reported · through program year 2025

Through program year 2025, Peter Bonutti of Effingham, IL is reported in the CMS Open Payments database as having received $24,294,201 across 253 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $574,795 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,178,137 9
2024 General $2,141,702 13
2023 General $6,385,096 23
2022 General $2,479,071 52
2021 General $3,728,162 37
2020 General $3,460,569 34
2019 General $3,921,463 85
2020 Ownership $50,000 2
2019 Ownership $524,795 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Peter Bonutti
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Peter Bonutti were reported at $2,178,137. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Peter Bonutti Orthopaedic Surgery median Middle half National median
2019 $3,921,463 $644 $140–$2,844 $163
2020 $3,460,569 $312 $75–$1,860 $114
2021 $3,728,162 $520 $117–$2,495 $132
2022 $2,479,071 $598 $128–$2,731 $149
2023 $6,385,096 $461 $128–$2,264 $160
2024 $2,141,702 $497 $134–$2,475 $164
2025 $2,178,137 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $16,235,271 210 payments
  2. Zimmer Biomet Holdings, Inc. $8,058,845 40 payments
  3. Smith+Nephew, Inc. $77 2 payments
  4. Orthofix Medical, Inc. $9 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $24,265,894 85 payments
  2. Travel and Lodging $23,306 59 payments
  3. Food and Beverage $5,001 109 payments
Products named General payments · program years 2019–2025
  1. REUNION Trauma & Extremeties $4,996,956 18 payments
  2. ACCOLADE Hips $4,662,583 25 payments
  3. TRIDENT Hips $4,662,261 16 payments
  4. BIOLOX $4,662,261 16 payments
  5. REUNION Trauma & Extremeties $4,048,646 15 payments
  6. Juggerknotless Soft Anchor $4,030,867 15 payments
  7. MAKO $4,014,532 43 payments
  8. ACCOLADE Hips $3,459,064 18 payments
  9. TRIDENT Hips $2,690,594 10 payments
  10. SONICANCHOR $2,400,000 10 payments
  11. Other $4,778,187 132 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

47

Median for Orthopedic Surgery: 203

Drug cost

$126

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Prednisone Generic 35 $106
Meloxicam Generic 12 $20

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 32 billing codes

Paid by Medicare

$207,186

Of which drugs: $78

Medicare patients

250

Average age 73

Services billed

660

143 women, 107 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 28%
Diabetes 25%
Depression 22%
Chronic kidney disease 18%
Atrial fibrillation 16%
COPD 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

253 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record